# Vasodilatory and Metabolic Effects of Glucagon-like Peptide-1 in Periphery Circulation in Patients With and Without Type 2 Diabetes Mellitus

> **NCT01689051** · NA · COMPLETED · sponsor: **University Hospital, Gentofte, Copenhagen** · enrollment: 20 (actual)

## Conditions studied

- Type 2 Diabetes
- Blod Pressure
- Glucagon-like Peptide-1
- Human Physiology
- Blood Flow

## Interventions

- **OTHER:** human glucagon-like peptide 1 (7-36)amide
- **OTHER:** human glucagon-like peptide 1 (9-36)amide

## Key facts

- **NCT ID:** NCT01689051
- **Lead sponsor:** University Hospital, Gentofte, Copenhagen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2013-04
- **Final completion:** 2013-04
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2014-01-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01689051

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01689051, "Vasodilatory and Metabolic Effects of Glucagon-like Peptide-1 in Periphery Circulation in Patients With and Without Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01689051. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*